Theranos names execs to lead compliance, regulatory affairs
Posted July 21, 2016 7:00 am
NEW YORK (AP) - Theranos Inc. named a new vice president in charge of regulatory issues and a new chief compliance officer weeks after federal regulators banned the company's founder and CEO from owning or running a medical laboratory for two years.
The ban followed months of investigation by government testing regulators where they found a number of violations of federal testing standards at the blood-test company's site. The action followed stories by The Wall Street Journal in which former employees said the company's tests were unreliable.
Theranos named Dave Wurtz as vice president of regulatory and quality and it named Daniel Guggenheim, as its chief compliance officer.
They report to CEO Elizabeth Holmes.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.